Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 38-44, January 2006

Radiation Combined With EGFR Signal Inhibitors: Head and Neck Cancer Focus

  • Paul M. Harari, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Paul M. Harari, MD, Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, 600 Highland Avenue, Madison, WI 53792
    • ,
  • Shyhmin Huang, PhD

University of Wisconsin Medical School and Comprehensive Cancer Center, Madison, WI

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr. Harari holds research and consulting agreements with AstraZeneca, Genentech, ImClone, Bristol-Myers and Amgen.

PII: S1053-4296(05)00049-4

doi:10.1016/j.semradonc.2005.08.005

Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 38-44, January 2006

Article Tools

* Image Usage & Resolution